Synercid

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2016
05101519952016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
The resistance of 330 coagulase-negative staphylococci (CNS) associated with food or used in starter cultures and belonging to… (More)
Is this relevant?
2003
2003
Synercid is a combination of two semisynthetic pristinamycin derivatives, quinupristin and dalfopristin in 30:70 (w/w) ratio. A… (More)
Is this relevant?
2003
2003
Synercid, a new semisynthetic streptogramin-derived antibiotic containing dalfopristin and quinupristin, is used in treatment of… (More)
Is this relevant?
2001
2001
In vitro activity of Quinupristin-dalfopristin (Synercid) against seventeen isolates of Borrelia burgdorferi and two… (More)
Is this relevant?
2000
2000
Quinupristin/dalfopristin (Synercid) is an i.v. antibiotic active against serious Gram-positive infections. Its unique dual mode… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Here we describe repressible (PipOFF) as well as inducible (PipON) systems for regulated gene expression in mammalian cells… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2000
2000
Safety and efficacy of quinupristin-dalfopristin (an injectable streptogramin antibiotic) were evaluated in the treatment of a… (More)
Is this relevant?
1999
1999
A progressive increase in the incidence of vancomycin resistance in strains of Enterococcus faecium (VREF) has severely… (More)
Is this relevant?
1999
1999
Quinupristin/dalfopristin (Synercid), the first injectable streptogramin antibiotic available for the treatment of complicated… (More)
Is this relevant?
1998
1998
A total of 200 medical center laboratories in the USA and Canada contributed results of testing quinupristin-dalfopristin, a… (More)
Is this relevant?